Wound-healing spray moves to Phase III clinical trials

04/16/2013 | WTAJ-TV (Altoona, Pa.)

Patients are being recruited for Phase III clinical trials of a spray containing human cells that release growth factors into a wound to encourage tissue regeneration. Wounds treated with the spray were 52% more likely to heal than those treated with compression bandages in earlier trials.

View Full Article in:

WTAJ-TV (Altoona, Pa.)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
PacificSource
Bend, OR
Clinical Appeals RN
MJHS
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ